Abstract
Aims/hypothesis
A range of prediction rules for the onset of type 2 diabetes have been proposed. However, most studies have been conducted in white groups and it is not clear whether these models apply to Asian populations. The purpose of this study was to construct a simple points model for predicting incident diabetes among Chinese people.
Methods
We estimated the 10 year risk of diabetes in a cohort study of middle-aged and elderly participants who were free from diabetes at baseline. Cox regression coefficients were used to construct the simple points model and the discriminatory ability of the resulting prediction rule was determined using AUC and net reclassification improvement and integrated discrimination improvement statistics. Fivefold random splitting was used to test the internal validity and obtain bootstrap estimates of the AUC.
Results
Of the 2,960 participants without diabetes at the baseline examination, 548 developed type 2 diabetes during a median 10 year follow-up period. Age (four points), elevated fasting glucose (11 points), body mass index (eight points), triacylglycerol (five points), white blood cell count (four points) and a higher HDL-cholesterol (negative four points) were found to strongly predict diabetes incidence in a multivariate model. The estimated AUC for the model was 0.702 (95% CI 0.676–0.727). This model performed better than existing prediction models developed in other populations, including the Prospective Cardiovascular Münster, Cambridge, San Antonia and Framingham models for diabetes risk.
Conclusions/interpretation
We have constructed a model for predicting the 10 year incidence of diabetes in Chinese people that could be useful for identifying individuals at high risk of diabetes in the Chinese population.
Similar content being viewed by others
Introduction
Prevention of diabetes and its associated complications has become a major public health priority worldwide. Recent clinical trials demonstrated that lifestyle interventions in individuals with impaired glucose tolerance can substantially delay the development of diabetes [1, 2], providing a rationale for the identification of high-risk individuals so as to implement early lifestyle intervention strategies to prevent diabetes. The prediction models for the risk of diabetes can help to guide screening and interventions and to predict diabetes occurrence [3–5]. Routinely available and easily collected clinical and lifestyle-related information has been found to be effective for identifying diabetes cases [6–12]. In addition, a prediction model has been developed in Mexican Americans [13] and further tested in Japanese Americans [14]. This San Antonia model included a variety of diabetes risk factors, including age, sex, ethnicity, fasting glucose, systolic blood pressure, HDL-cholesterol, body mass index and family history, to generate a prediction points system and appeared to have a predictive power similar to that of the diagnostic criteria for metabolic syndrome [13, 15]. Several other prediction models have also been developed, primarily in white populations [3, 5, 16, 17]. However, risk scores developed in white people may not apply to other ethnic groups [18]. Therefore, we specifically developed a prediction model for type 2 diabetes using a community-based cohort of middle-aged and elderly Chinese in Taiwan.
Methods
Study design and participants
The National Taiwan University Hospital Committee Review Board approved the study protocol, details of which have been published previously [19, 20]. Briefly, the Chin-Shan Community Cardiovascular Cohort Study began in 1990 by recruiting 1,703 men and 1,899 women of Chinese ethnicity aged 35 years old or older from the Chin-Shan township, 30 km north of metropolitan Taipei, Taiwan. Information about anthropometry, lifestyle and medical conditions was assessed by interview questionnaires in 2 year cycles for the initial 6 years; the validity and reproducibility of the collected data and measurements have been reported in detail elsewhere [21]. Individuals with baseline incomplete blood data (n = 41), diagnosis of diabetes (fasting glucose ≥7.0 mmol/l or with a history of hypoglycaemic medication, n = 473), or history of cardiovascular disease or cancer (n = 170) were excluded from this investigation. After these exclusions, we included 2,960 individuals in this study. During the follow-up from 1990 to 2000, 548 individuals developed diabetes defined by fasting glucose levels ≥7.0 mmol/l or by the use of oral hypoglycaemic or insulin medication. The response rate of the cohort participants was 85.7% at the end of the study. All participants give informed consent.
Body mass index was calculated from weight (kg)/height2 (m2). Blood pressure was measured twice in the right arm using a mercury sphygmomanometer with the individual seated comfortably, arms supported and positioned at the level of the heart after resting for 10 min. Hypertension was defined according to the criteria established by the Seventh Joint National Committee [22]: systolic blood pressure ≥ 140 mmHg; diastolic blood pressure ≥90 mmHg; or history of hypertension medication. Family history was defined by any parental or first-degree sibling history of diabetes.
Measurement of biochemical markers
The procedure for blood collection has been reported elsewhere [23, 24]. Briefly, all venous blood samples drawn after a 12 h overnight fast were immediately refrigerated and transported within 6 h to the National Taiwan University Hospital. Serum samples were then stored at −70°C before batch assay for levels of total cholesterol, triacylglycerol, and HDL-cholesterol. Standard enzymatic tests for serum cholesterol and triacylglycerol were used (Merck 14354 and 14366, Merck, Darmstadt, Germany). HDL-cholesterol levels were measured in supernatant fractions after the precipitation of specimens with magnesium chloride phosphotungstate reagents (Merck 14993). LDL-cholesterol concentrations were calculated as total cholesterol minus cholesterol in the supernatant fraction by the precipitation method (Merck 14992) [25]. Blood samples for glucose analysis were drawn into glass test tubes each containing 80 mol/l fluoride/oxalate reagent. After centrifugation at 1,500×g for 10 min, the glucose level in the supernatant fraction was measured by enzymatic assay (Merck 3389) using an Eppendorf 5060 autoanalyzer. The peripheral-blood-cell analysis was carried out using the blood-cell counter (Sysmex Cell Counter NE-8000, TOA Medical Electronics, Kobe, Japan).
Statistical analysis
We used a multivariate Cox proportional hazards model to establish a parsimonious model for predicting risk of diabetes. This model included six significant predictors: age, body mass index, white blood cell count, triacylglycerol, HDL-cholesterol and fasting glucose. Because sex, family history of diabetes, hypertension and systolic blood pressure are biologically important predictors of the risk of diabetes [26], we examined the incremental predictive value of adding these variables to the above model. In addition, lifestyle factors such as physical activity, smoking and drinking alcohol were also tested to derive the parsimonious model. However, the likelihood ratio test suggested that adding these variables into the model did not improve prediction beyond the concise model. Thus, our final model did not include sex, hypertension or lifestyle factors.
We constructed the categorisation point system according to the concise model using the methods suggested by Sullivan and colleagues [27]. First, we organised the continuous variables into meaningful categories and determined reference values for each variable. Second, we determined the referent risk-factor profile by assigning the median value in each category and estimated how far each category was from the referent in regression units. Then we set a constant to reflect the increase in risk associated with a 10 year increase in age and decided points associated with each of the risk-factor categories. The point totals ranged from –15 to 32. Finally, we constructed the individual’s risk from the formula:
where S0(t) was the average survival at time t (e.g. t = 10 years) or the survival rate at the mean values of the risk factor, βX values were approximated from the sum of baseline risk and product of point totals and the constant. \(\beta \overline X \) values were the sum of the products of the regression coefficients and means or the proportions of the variables.
We also constructed the regression coefficient-based model by assigning β values as estimated regression coefficients.
We conducted the internal validation of the simple points model and obtained a bias-corrected estimate of the AUC using a fivefold cross-validation procedure [28]. We randomly split the data into five equal parts. For k = 1, ..., 5, we used the kth part as the validation dataset and the remaining four parts as the training dataset. For each partition of the validation and training sets, we obtained the coefficients from the training set and assigned the points from the coefficients in the validation set to evaluate performance by estimating the AUC for the corresponding simple points model. Then we evaluated the overall performance of the points model by averaging the AUC estimates obtained from the five different partitions. The ranges of AUC across the five partitions indicated the stability of the prediction model [29]. To account for the variability in estimating the model variables and the AUC, we used the bootstrap method to construct 95% confidence intervals for the AUC. The standard-error estimates and the confidence intervals were obtained based on 1,000 bootstrap samples.
Finally, we compared the performance of the proposed prediction model with that of various prediction models derived from other populations, including Cambridge [8–10], Prospective Cardiovascular Münster (PROCAM) [30], San Antonia [13, 14] and Framingham [5]. AUC was used to compare the discriminatory capabilities of these models and our simple points model. An AUC curve is a graph of sensitivity vs 1–specificity (or false-positive rate) for various cut-off definitions of a positive diagnostic test result [31]. We listed the sensitivity and specificity for the best cut-off values from various models. Statistical differences in the AUCs were compared using the method of DeLong et al. [32]. In addition, we assessed the goodness of fit for all models based on the Hosmer–Lemeshow test [33]. The global summary statistics, including Yates slope [34, 35], Brier score [34] and discrimination C statistics [36], were calculated in various models. Moreover, we compared the simple points model with other models by using the net reclassification improvement (NRI) and integrated discrimination improvement (IDI) statistics [37]. The NRI statistic was based on the reclassification tables and was calculated from a sum of differences between the ‘upward’ movement in categories for event participants and the ‘downward’ movement in those for non-event participants [37]. We presented the NRI according to the a priori risk categories of diabetes (0–15%, 15–20%, 20–25%, and ≥25%). The IDI can be interpreted as a difference between improvement in average sensitivity and any potential increase in average ‘1–specificity’, and the statistic was a difference in Yates discrimination slopes between the new and old models [34, 35].
We also ran a clinical model that included age, sex, BMI, family history and antihypertensive medication, but not requiring blood test results, and used the AUC to compare the predictive ability of this model with the model that included laboratory-based measures.
All statistical tests were two-sided with a type I error of 0.05, and p values < 0.05 were considered statistically significant. Analyses were performed with SAS version 9.1 (SAS Institute, Cary, NC, USA) and Stata version 9.1 (Stata Corporation, College Station, TX, USA).
Results
Of the 2,960 participants without diabetes at the baseline examination, 548 developed type 2 diabetes during a 10 year follow-up period. Among the 548 participants with incident diabetes, 396 were not receiving pharmacological treatment for diabetes and were given a diagnosis exclusively on the basis of plasma glucose levels that met the American Diabetes Association criteria (≥7.0 mmol/l). Of the 136 participants with confirmed pharmacological treatment for diabetes, 78 also met plasma glucose criteria for diabetes. The baseline characteristics of study participants and the results of a Cox multivariate analysis that included age, body mass index, white cell count, triacylglycerol, HDL-cholesterol and fasting glucose level are shown in Table 1. Participants who developed incident diabetes also tended to have increased systolic blood pressure and a higher prevalence of family history of diabetes, but these two variables were not significantly associated with risk of diabetes after adjustment for other covariates. Therefore, they were not included in the final model.
We developed a simple points system to estimate the diabetes risk using the baseline survival function at 10 years and the coefficients of the concise model (Table 2): age (four points), elevated fasting glucose (11 points), body mass index (eight points), triacylglycerol (five points), white blood cell count (four points) and a higher HDL-cholesterol (negative four points). This approach allowed manual estimation of 10 year risk of developing diabetes for each individual, as shown in Table 3.
By using the simple points system to estimate risk of incident diabetes during a 10 year follow-up interval, we determined that 42% of the sample had a risk below 20%, 28% had risk a 20–30% risk, and 30% had a risk of 30% or higher. This simple points model has a good discriminatory ability with an AUC of 0.702 (95% CI 0.676–0.727). Adding sex, hypertension and family history of diabetes did not improve the predictive power (AUC 0.700, 95% CI 0.675–0.725). In addition, the regression-coefficient-based model has a similar AUC value (0.701, 95% CI 0.675–0.726). The optimal cut-off value for the simple points model was set as 13, with a sensitivity of 0.52 and a specificity of 0.78 (Table 4). We found that the simple points model had the highest proportions of correctly classified and best likelihood ratio values among all models, and had a Youden index value similar to those of the coefficient-based models. The clinical model based on anthropometric measures and medication had a lower predictive ability (AUC 0.646, 95% CI 0.621–0.672) than the simple points model that included blood test results (p < 0.001).
The within-study model validation was assessed by the aforementioned fivefold cross-validation procedure. The AUCs for the five partitions ranged from 0.664 to 0.711, indicating a moderately high reliability of discrimination for the model in repeated random-sample subsets. The AUCs from the PROCAM, Cambridge, San Antonia and Framingham models were significantly lower than that from our simple points model (Fig. 1).
Table 5 presents summary statistics for the performance of models in terms of predicting diabetes risk in the cohort dataset. The simple points model had the highest Yates’ slope and C statistics, indicating good discriminatory ability. When comparing the predicted and observed risks, we observed a non-significant p value for the Hosmer–Lemeshow statistics for the simple points model, indicating good calibration. The San Antonia model was most similar to the simple points model, with the smallest NRI and IDI values and the highest correlation coefficient. In addition, we calculated the NRI according to different risk categories and the results were similar. We found the NRI values were similar in the quartiles and the 15–20–25% risk categories.
Discussion
Statement of principal findings
Using a community-based cohort study, we developed a simple points model to predict 10 year risk of type 2 diabetes in a Chinese population based on six variables: age, body mass index, white blood cell count, triacylglycerol, HDL-cholesterol and fasting glucose levels. These values could be relatively easily obtained in clinical practice and the points system we developed is simple to use. The availability of the simple clinical tool to predict future risk of disease, as has been the case for prediction of coronary heart disease, should improve the prediction of diabetes risk, identify high-risk populations and enhance preventive strategies.
Existing diabetes risk functions
Several diabetes-prediction models have previously been developed in various populations. In cross-sectional studies conducted in the USA and Europe, prediction models based on clinical information and lifestyle-related factors have appeared to be useful for identifying undiagnosed diabetes cases and high HbA1c levels in screening populations [7, 8, 38, 39]. For example, the Cambridge model has been applied successfully to identify individuals with high HbA1c levels [9, 10]. In addition, a recent cohort study showed that the Cambridge model was useful for identifying individuals with a higher risk of type 2 diabetes during follow-up [40]. Other cohort-based risk models, such as the FINDRISC (Finnish Diabetes Risk Score) [3], PROCAM [30], San Antonia [13] and Framingham models [5], were developed to predict incident diabetes in different populations. We did not compare our model with FINDRISC or the German risk score [17, 41] because dietary information, which is needed for risk scoring, was not collected from our cohort.
Using age, body mass index, fasting glucose, HDL-cholesterol, family history and hypertension status, von Eckardstein and colleagues developed a model (PROCAM) to predict the incidence of diabetes during 6.3 years of follow-up in a German population [30]. Stern and colleagues also constructed the San Antonia model to predict diabetes risk in Mexican Americans and non-Hispanic whites during a 7.5-year follow-up period [13] and this model was validated among Japanese Americans during a 10 year follow-up period [14]. The San Antonia model included biomarkers such as fasting glucose, blood pressure and HDL-cholesterol, in addition to age, sex, obesity and family history of diabetes. Recently, Wilson and colleagues developed a simple points diabetes-prediction model for the Framingham Offspring Study [5]. This model included fasting glucose, body mass index, HDL-cholesterol, family history of diabetes, triacylglycerol and hypertension. Among these models, only the San Antonia model resembled our simple points model in terms of predictive power (see Electronic supplementary material [ESM] Table 1).
Most of the variables included in our model were similar to those in previous risk functions. Moreover, white cell count, a marker of chronic inflammation, was incorporated into our prediction model. In addition to fasting glucose and BMI, metabolic variables such as high triacylglycerol and low HDL-cholesterol were found to be strong predictors of type 2 diabetes in our study. These variables in our model have also been included in prediction model developed for other populations [39, 42]. Moreover, we found that BMI had a discriminatory power similar to that of waist circumference in our model. Although family history of diabetes and hypertension were important predictors of diabetes in other studies, adding these variables to our risk scores did not improve risk prediction. In addition, we did not include lifestyle factors such as physical activity and smoking because they were not significant predictors of diabetes after adjusting for other risk factors.
Strengths and weaknesses of the study
To our knowledge, this is the first diabetes prediction model specifically developed for a Chinese population. Because of the large sample size, the estimates from our prediction models were found to be stable, as demonstrated by the internal validation study. Also, the use of a community-based population could reduce the possibility of selection bias. However, several potential limitations of this study should be mentioned.
First, the discriminatory capability of our simple points model was only moderately high (the AUCs were ∼0.70), and somewhat lower than that of other prediction models from other populations.
Second, we did not include extensive biomarker data in the model. Adding other biomarkers such as insulin resistance may improve the discriminatory ability. However, these variables are more difficult to measure and interpret in clinical practice.
Third, our cohort has a higher diabetes incidence rate than Chinese women in Shanghai, China [43]. The high risk of diabetes among our study participants may be explained by older age, higher body mass index and a single measurement for case diagnosis [44].
Fourth, fasting plasma glucose but not post-challenge glucose was used to define the incidence of diabetes and to exclude individuals with undiagnosed diabetes at baseline. This is likely to have led to some error in estimation of the risk of diabetes and hence the performance of our model. Although fasting glucose is widely measured in routine health checkups in Taiwan [45], our model may be less practical in other populations in which blood test results for white cell count and fasting glucose, triacylglycerol and cholesterol are not routinely available or easily obtained.
In conclusion, we have constructed a simple points model for predicting the 10 year incidence of diabetes, and this model performed significantly better than other existing diabetes prediction models within the study population of ethnic Chinese people. This simple clinical tool should help identify high-risk populations and improve preventive and treatment strategies for the Chinese population.
Abbreviations
- IDI:
-
integrated discrimination improvement
- NRI:
-
net reclassification improvement
- PROCAM:
-
Prospective Cardiovascular Münster
References
Tuomilehto J, Lindstrom J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350
Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403
Lindstrom J, Tuomilehto J (2003) The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 26:725–731
Schmidt MI, Duncan BB, Bang H et al (2005) Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study. Diabetes Care 28:2013–2018
Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, D’Agostino RB Sr (2007) Prediction of Incident Diabetes Mellitus in Middle-aged Adults: The Framingham Offspring Study. Arch Intern Med 167:1068–1074
Baan CA, Ruige JB, Stolk RP et al (1999) Performance of a predictive model to identify undiagnosed diabetes in a health care setting. Diabetes Care 22:213–219
Glumer C, Carstensen B, Sandbaek A, Lauritzen T, Jorgensen T, Borch-Johnsen K (2004) A Danish diabetes risk score for targeted screening: the Inter99 study. Diabetes Care 27:727–733
Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ (2000) Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 16:164–171
Park PJ, Griffin SJ, Sargeant L, Wareham NJ (2002) The performance of a risk score in predicting undiagnosed hyperglycemia. Diabetes Care 25:984–988
Thomas C, Hypponen E, Power C (2006) Type 2 diabetes mellitus in midlife estimated from the Cambridge Risk Score and body mass index. Arch Intern Med 166:682–688
Al-Lawati JA, Tuomilehto J (2007) Diabetes risk score in Oman: a tool to identify prevalent type 2 diabetes among Arabs of the Middle East. Diabetes Res Clin Pract 77:438–444
Ramachandran A, Snehalatha C, Vijay V, Wareham NJ, Colagiuri S (2005) Derivation and validation of diabetes risk score for urban Asian Indians. Diabetes Res Clin Pract 70:63–70
Stern MP, Williams K, Haffner SM (2002) Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 136:575–581
McNeely MJ, Boyko EJ, Leonetti DL, Kahn SE, Fujimoto WY (2003) Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans. Diabetes Care 26:758–763
Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM (2003) The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 26:3153–3159
Herman WH, Smith PJ, Thompson TJ, Engelgau MM, Aubert RE (1995) A new and simple questionnaire to identify people at increased risk for undiagnosed diabetes. Diabetes Care 18:382–387
Schulze MB, Hoffmann K, Boeing H et al (2007) An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes. Diabetes Care 30:510–515
Glumer C, Vistisen D, Borch-Johnsen K, Colagiuri S (2006) Risk scores for type 2 diabetes can be applied in some populations but not all. Diabetes Care 29:410–414
Chien KL, Hsu HC, Su TC, Chen MF, Lee YT, Hu FB (2007) Apolipoprotein B and non-high-density lipoprotein cholesterol and risk of coronary heart disease in Chinese. J Lipid Res 48:2499–2505
Lee YT, Lin RS, Sung FC et al (2000) Chin-Shan Community Cardiovascular Cohort in Taiwan: baseline data and five-year follow-up morbidity and mortality. Journal of Clinical Epidemiology 53:836–846
Lee YT, Sung FC, Lin RS et al (2001) Peripheral blood cells among community residents living near nuclear power plants. Science of the Total Environment 280:165–172
Chobanian AV, Bakris GL, Black HR et al (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289:2560–2572
Chien KL, Lee YT, Sung FC, Hsu HC, Su TC, Lin RS (1999) Hyperinsulinemia and related atherosclerotic risk factors in the population at cardiovascular risk: a community-based study. Clinical Chemistry 45:838–846
Chien KL, Sung FC, Hsu HC, Su TC, Chang WD, Lee YT (2005) Relative importance of atherosclerotic risk factors for coronary heart disease in Taiwan. Eur J Cardiovasc Prev Rehabil 12:95–101
Wieland H, Seidel D (1983) A simple specific method for precipitation of low density lipoproteins. Journal of Lipid Research 24:904–909
Schulze MB, Hu FB (2005) Primary prevention of diabetes: what can be done and how much can be prevented? Annu Rev Public Health 26:445–467
Sullivan LM, Massaro JM, D’Agostino RB Sr (2004) Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Stat Med 23:1631–1660
Efron B, Tibshirani RJ (1994) An introduction to the bootstrap. Chapman & Hall/CRC, Boca Raton
Cai T, Zheng Y (2007) Model checking for ROC regression analysis. Biometrics 63:152–163
von Eckardstein A, Schulte H, Assmann G (2000) Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Prospective Cardiovascular Munster. J Clin Endocrinol Metab 85:3101–3108
Hanley JA, McNeil BJ (1983) A method of comparing the areas under receive operating characteristic curves derived from the same cases. Radiology 148:839–843
DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845
Hosmer DW Jr, Lemeshow S (1989) The multiple logistic regression model. In: Applied Logistic Regression. Wiley, New York, pp 25–37
Yates J (1982) External correspondence: decomposition of the mean probability score. Organizational Behavior and Human Performance 30:132–156
Schmid C, Griffith J (1998) Multivariable classification rules: calibration and discrimination. In: Armitage P, Colton T (eds) Encyclopedia of Biostatistics. Wiley, Chichester
Cook NR (2007) Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115:928–935
Pencina MJ, D’Agostino RBS, D’Agostino RBJ, Vasan RS (2008) Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat Med 27:157–172
Diabetes Prevention Program Research Group (2005) Strategies to identify adults at high risk for type 2 diabetes: the Diabetes Prevention Program. Diabetes Care 28:138–144
Kanaya AM, Wassel Fyr CL, de Rekeneire N et al (2005) Predicting the development of diabetes in older adults: the derivation and validation of a prediction rule. Diabetes Care 28:404–408
Rahman M, Simmons RK, Harding AH, Wareham NJ, Griffin SJ (2008) A simple risk score identifies individuals at high risk of developing Type 2 diabetes: a prospective cohort study. Fam Pract 25:191–196
Silventoinen K, Pankow J, Lindstrom J, Jousilahti P, Hu G, Tuomilehto J (2005) The validity of the Finnish Diabetes Risk Score for the prediction of the incidence of coronary heart disease and stroke, and total mortality. Eur J Cardiovasc Prev Rehabil 12:451–458
D’Agostino RB Jr, Hamman RF, Karter AJ, Mykkanen L, Wagenknecht LE, Haffner SM (2004) Cardiovascular disease risk factors predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes Care 27:2234–2240
Villegas R, Liu S, Gao YT et al (2007) Prospective study of dietary carbohydrates, glycemic index, glycemic load, and incidence of type 2 diabetes mellitus in middle-aged Chinese women. Arch Intern Med 167:2310–2316
Chien KL, Chen MF, Hsu HC et al (2008) Plasma Uric Acid and the Risk of Type 2 Diabetes in a Chinese Community. Clin Chem 54:310–316
Chen TH, Chiu YH, Luh DL et al (2004) Community-based multiple screening model: design, implementation, and analysis of 42,387 participants. Cancer 100:1734–1743
Acknowledgements
We thank the participants in the Chin-Shan community and the cardiologists at the National Taiwan University Hospital for their assistance in this study. This study was supported partly by grants from the National Science Council in Taiwan. F. Hu’s research is partly supported by the American Heart Association Established Investigator Award. We are thankful to M. Pencina for kindly providing the SAS macro for computing NRI and IDI statistics.
Duality of interest
The authors declare that there is no duality of interest associated with this manuscript
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM Table 1
Literature review of prospective cohort studies of prediction models for type 2 diabetes (PDF 51.7 kb)
Rights and permissions
About this article
Cite this article
Chien, K., Cai, T., Hsu, H. et al. A prediction model for type 2 diabetes risk among Chinese people. Diabetologia 52, 443–450 (2009). https://doi.org/10.1007/s00125-008-1232-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00125-008-1232-4